Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 5/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 10/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3324292 | 1.00 | SLC6A4 (0.39) | SLC6A4LMNAMAPTATML3MBTL1 | |
| SCHEMBL3323710 | 0.90 | KDM4E (0.34) | MAPT | |
| SCHEMBL3323706 | 0.90 | KDM4E (0.34) | MAPT | |
| SCHEMBL3324786 | 0.86 | SLC6A4 (0.34) | SLC6A4LMNAPPARDSLC6A2SLC6A3 | |
| SCHEMBL3326015 | 0.86 | SLC6A4 (0.34) | SLC6A4LMNAPPARDPPARASLC6A2 | |
| SCHEMBL3326013 | 0.86 | SLC6A4 (0.34) | SLC6A4LMNAPPARDPPARASLC6A2 | |
| SCHEMBL3324790 | 0.86 | SLC6A4 (0.34) | SLC6A4LMNAPPARDSLC6A2SLC6A3 | |
| SCHEMBL12710229 | 0.85 | SLC6A4 (0.35) | SLC6A4MAPTPPARDSCN9ASLC6A2 | |
| SCHEMBL3323221 | 0.85 | PPARD (0.35) | PPARD | |
| SCHEMBL3322067 | 0.85 | SLC6A4 (0.35) | SLC6A4MAPTPPARDSCN9ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299302-B2 | 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides | BAYER CROPSCIENCE AG (DE) | 2012-10-30 | — | — | US | claimed |
| US-20100120615-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-05-13 | — | — | US | claimed |
| EP-1969934-A1 | 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides | Bayer CropScience AG (DE) | 2008-09-17 | — | — | EP | claimed |
| US-8748662-B2 | 4-cycloalkyl or 4-aryl substituted phenoxyphenylamidines and use thereof as fungicides | BAYER CROPSCIENCE AG (DE) | 2014-06-10 | — | — | US | disclosed |
| US-20130012742-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2013-01-10 | — | — | US | disclosed |
| US-8299302-B2 | 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides | BAYER CROPSCIENCE AG (DE) | 2012-10-30 | — | — | US | disclosed |
| US-20100120615-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-05-13 | — | — | US | disclosed |
| EP-2120560-A1 | 4-CYCLOALKYL OR 4-ARYL SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008110315-A1 | 4-CYCLOALKYL OR 4-ARYL SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE TEHROF AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2008-09-18 | — | — | WO | disclosed |
| EP-1969934-A1 | 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides | Bayer CropScience AG (DE) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120615-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | DDT, CYP4B1, PAH | SLC6A4 895/4885LMNA 4403/4885MAPT 3280/4885 |
| US-20130012742-A1 | 4-CYCLOALKYL OR 4-SUBSTITUTED PHENOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES | DDT, CYP4B1, PAH | SLC6A4 895/4885LMNA 4403/4885MAPT 3280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.